MicroRNA-134 Modulates the Differentiation of Mouse Embryonic Stem Cells, Where It Causes Post-Transcriptional Attenuation of Nanog and LRH1
Yvonne Tay(Beth Israel Deaconess Medical Center), Bing Lim(DecImmune Therapeutics (United States))
Cited by 235
Related Papers
MicroRNA-125b is a novel negative regulator of p53
|Genes & Development|2009|648
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
|Cancer Cell|2013|320
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression
|Nature Communications|2016|216
Moving AHEAD with an international human epigenome project
|Nature|2008|185